This content is from: India

Mumbai ITAT sides with OECD on location savings in Watson Pharma case

The Income-Tax Appellate Tribunal (ITAT) in Mumbai has ruled in favour of Watson Pharma Private, rejecting India’s views on location savings advantages in favour of the OECD perspective.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial